Published in J Hepatol on December 01, 1994
Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. Cancer (2009) 2.19
Steatosis in chronic hepatitis C: why does it really matter? Gut (2006) 2.10
Newly diagnosed diabetes mellitus as a risk factor for serious liver disease. CMAJ (2010) 1.95
Hepatitis C virus and type 2 diabetes. World J Gastroenterol (2009) 1.57
Prospective study of liver transplant recipients with HCV infection: evidence for a causal relationship between HCV and insulin resistance. Liver Transpl (2008) 1.50
Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt. Gut (2006) 1.34
Relationship between hepatitis C virus infection and type 2 diabetes mellitus: meta-analysis. World J Gastroenterol (2012) 1.22
Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients. World J Gastroenterol (2007) 1.15
Hepatitis C virus activates the mTOR/S6K1 signaling pathway in inhibiting IRS-1 function for insulin resistance. J Virol (2012) 1.09
Mechanisms and significance of liver steatosis in hepatitis C virus infection. World J Gastroenterol (2006) 1.09
Involvement of the PA28gamma-dependent pathway in insulin resistance induced by hepatitis C virus core protein. J Virol (2006) 1.08
Nonhepatic manifestations and combined diseases in HCV infection. Dig Dis Sci (1996) 1.06
Prevalence of type 2 diabetes in Algerian patients with hepatitis C virus infection. World J Gastroenterol (2010) 1.01
Epidemiology of hepatitis C virus in Iran. World J Gastroenterol (2015) 1.01
Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3. Gut (2011) 1.00
Pregnancy complications associated with hepatitis C: data from a 2003-2005 Washington state birth cohort. Am J Obstet Gynecol (2008) 1.00
Clinical features of hepatitis C virus carriers with persistently normal alanine aminotransferase levels. Hepat Mon (2012) 0.99
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus. World J Diabetes (2014) 0.98
Molecular mechanisms of insulin resistance in chronic hepatitis C. World J Gastroenterol (2009) 0.98
Association of hepatitis C virus infection and diabetes in central Tunisia. World J Gastroenterol (2009) 0.98
Importance of hepatitis C virus-associated insulin resistance: therapeutic strategies for insulin sensitization. World J Gastroenterol (2010) 0.97
Diabetes mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C. Dig Dis Sci (2002) 0.95
Surgical results in patients with hepatitis virus-related hepatocellular carcinoma in Taiwan. World J Surg (2002) 0.94
Chronic HCV infection was associated with severe insulin resistance and mild atherosclerosis: a population-based study in an HCV hyperendemic area. J Gastroenterol (2012) 0.93
Diabetes mellitus during interferon therapy for chronic viral hepatitis. Dig Dis Sci (2002) 0.91
Seroprevalence of hepatitis C in type 2 diabetes: evidence for a positive association. Virol J (2010) 0.90
Diabetes and Hepatitis C: A Two-Way Association. Front Endocrinol (Lausanne) (2015) 0.89
Insulin resistance and chronic liver disease. World J Hepatol (2011) 0.88
Exaggerated liver injury induced by renal ischemia reperfusion in diabetes: effect of exenatide. Saudi J Gastroenterol (2010) 0.87
Interaction between hepatitis C virus and metabolic factors. World J Gastroenterol (2014) 0.87
Mode of hepatitis C virus infection, epidemiology, and chronicity rate in the general population and risk groups. Dig Dis Sci (1996) 0.87
Metabolic profiles in patients with chronic hepatitis C: a case-control study. Hepatol Int (2008) 0.86
Successful Hepatitis C Antiviral Therapy Induces Remission of Type 2 Diabetes: A Case Report. Am J Case Rep (2015) 0.86
Insulin resistance is common in patients with predominantly genotype 3 chronic hepatitis C. Dig Dis Sci (2009) 0.86
Effects of Nigella sativa on outcome of hepatitis C in Egypt. World J Gastroenterol (2013) 0.86
Clearance of HCV by Combination Therapy of Pegylated Interferon alpha-2a and Ribavirin Improves Insulin Resistance. Gut Liver (2009) 0.85
Clinical expression of insulin resistance in hepatitis C and B virus-related chronic hepatitis: differences and similarities. World J Gastroenterol (2009) 0.85
Impact of liver diseases on the development of type 2 diabetes mellitus. World J Gastroenterol (2011) 0.85
Hepatitis C virus induced a novel apoptosis-like death of pancreatic beta cells through a caspase 3-dependent pathway. PLoS One (2012) 0.84
Prevalence of type 2 diabetes mellitus in hepatitis C virus infected population: a Southeast Asian study. J Diabetes Res (2013) 0.84
Association of chronic hepatitis C virus infection and diabetes mellitus in Korean patients. Korean J Intern Med (2001) 0.84
Diabetes mellitus is associated with impaired response to antiviral therapy in chronic hepatitis C infection. Dig Dis Sci (2009) 0.83
Update on chronic viral hepatitis. Postgrad Med J (2001) 0.83
Glucose intolerance in Chinese patients with chronic hepatitis C. World J Gastroenterol (2003) 0.83
Liver cirrhosis and diabetes mellitus. J Hepatol (1996) 0.81
Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults. AIDS (2017) 0.81
Prevalence of diabetes and incidence of angiopathy in patients with chronic viral liver disease. J Clin Biochem Nutr (2007) 0.80
APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing. Hepatol Int (2016) 0.79
Peroxisome proliferator-activated receptors and hepatitis C virus. Therap Adv Gastroenterol (2011) 0.79
Hepatitis C Virus infection in apparentenly healthy individuals with family history of diabetes in Vom, Plateau State Nigeria. Virol J (2009) 0.79
Current level of evidence on causal association between hepatitis C virus and type 2 diabetes: A review. J Adv Res (2016) 0.79
Seroprevalence of Hepatitis B and C Viral Infections among Type 2 Diabetics: A Cross-sectional Study in the Cape Coast Metropolis. Ann Med Health Sci Res (2014) 0.78
Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy. World J Gastroenterol (2014) 0.78
The effect of hepatitis C virus infection on insulin resistance in chronic haemodialysis patients. Yonsei Med J (2007) 0.78
Effect of ribavirin alone or combined with silymarin on carbon tetrachloride induced hepatic damage in rats. Drug Target Insights (2007) 0.78
HCV synergizes with body weight in the promotion of insulin resistance. J Viral Hepat (2011) 0.78
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV. World J Gastroenterol (2016) 0.77
Predictors of insulin resistance among Hispanic adults infected with or at risk of infection with the human immunodeficiency virus and hepatitis C virus. J Viral Hepat (2008) 0.77
To study the prevalence of impaired glucose tolerance in patients with hepatitis C virus related chronic liver disease. J Clin Diagn Res (2015) 0.77
Metabolic syndrome in chronic hepatitis C infection: does it still matter in the era of directly acting antiviral therapy? Hepat Med (2014) 0.77
Viruses and diabetes: is there something sweet about hepatitis C infection? Ochsner J (2001) 0.77
Relation of insulin resistance and liver fibrosis progression in patients with chronic hepatitis C virus infection. Int J Health Sci (Qassim) (2009) 0.77
Exacerbation of chronic inflammatory diseases by infectious agents: Fact or fiction? World J Diabetes (2010) 0.77
Insulin Resistance is Associated With Significant Liver Fibrosis in Chronic Hepatitis C Patients: A Systemic Review and Meta-Analysis. J Clin Gastroenterol (2016) 0.76
Ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, ameliorates the development of liver fibrosis in diabetic Otsuka Long-Evans Tokushima fatty rats. J Gastroenterol (2016) 0.76
Hepatitis C and insulin action: An intimate relationship. World J Hepatol (2016) 0.76
Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection-Liver: The "Musketeer" in the Spotlight. Int J Mol Sci (2016) 0.76
Epidemiology of hepatitis C in Greece. World J Gastroenterol (2016) 0.75
Glucose abnormalities in Asian patients with chronic hepatitis C. Drug Des Devel Ther (2015) 0.75
A Different Perspective for Management of Diabetes Mellitus: Controlling Viral Liver Diseases. J Diabetes Res (2017) 0.75
Application of network construction to estimate functional changes to insulin receptor substrates 1 and 2 in Huh7 cells following infection with the hepatitis C virus. Mol Med Rep (2016) 0.75
Metabolic Derangement in Acute and Chronic Liver Disorders. Indian J Endocrinol Metab (2017) 0.75
Hepatitis C virus induces a pre-diabetic state by directly impairing hepatic glucose metabolism in mice. J Biol Chem (2017) 0.75
Hepatitis B and C seroprevalence in patients with diabetes mellitus and its relationship with microvascular complications. Prz Gastroenterol (2016) 0.75
Hepatitis C as a systemic disease: virus and host immunologic responses underlie hepatic and extrahepatic manifestations. J Gastroenterol (2007) 0.75
Chronic hepatitis C virus infection: a new modifiable cardio-metabolic risk factor? Clujul Med (2017) 0.75
New-onset diabetes mellitus after living-donor liver transplantation: association with graft synthetic function. Surg Today (2016) 0.75
Early indicators of prognosis in fulminant hepatic failure. Gastroenterology (1989) 7.43
Differences in mortality after fracture of hip: the east Anglian audit. BMJ (1995) 6.12
Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology (1999) 4.59
Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet (1990) 4.27
A new mobility score for predicting mortality after hip fracture. J Bone Joint Surg Br (1993) 4.19
Injury patterns in cyclists attending an accident and emergency department: a comparison of helmet wearers and non-wearers. BMJ (1994) 3.89
Optimisation of antihypertensive treatment by crossover rotation of four major classes. Lancet (1999) 3.69
Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ (1991) 2.94
Rates of admission to hospital for asthma. BMJ (1994) 2.87
Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med (1991) 2.65
Recessive inheritance of erythropoietic protoporphyria with liver failure. Lancet (1994) 2.42
Undiagnosed glucose intolerance in the community: the Isle of Ely Diabetes Project. Diabet Med (1995) 2.20
Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure. BMJ (1990) 2.18
Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology (1999) 2.02
Concentrations of interleukin 6 and tumour necrosis factor in serum and stools of children with Shigella dysenteriae 1 infection. Gut (1993) 1.98
Evidence that hepatitis D virus needs hepatitis B virus to cause hepatocellular damage. Am J Clin Pathol (1992) 1.98
Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection. Lancet (1987) 1.87
LSD: injection early in pregnancy produces abnormalities in offspring of rats. Science (1967) 1.86
Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11. Euro Surveill (2011) 1.84
Quality improvement for patients with hip fracture: experience from a multi-site audit. Qual Saf Health Care (2002) 1.83
Sweeping the membranes: a valid procedure in stimulating the onset of labour? Br J Obstet Gynaecol (1993) 1.83
Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet (1988) 1.82
A randomized, controlled trial of routine early abdominal computed tomography in patients presenting with non-specific acute abdominal pain. Clin Radiol (2007) 1.70
Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation. Lancet (1987) 1.68
Prediction of rehabilitation after hip fracture. Age Ageing (1995) 1.66
The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood (1998) 1.66
Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology (1991) 1.65
VEGF mRNA levels in placentae from pregnancies complicated by pre-eclampsia. Br J Obstet Gynaecol (1996) 1.63
Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. J Heart Lung Transplant (1998) 1.63
Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. Euro Surveill (2011) 1.61
Mechanism of DNA-binding enhancement by the human T-cell leukaemia virus transactivator Tax. Nature (1995) 1.61
Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med (1990) 1.60
Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation. Lancet (1988) 1.60
Acute liver decompensation on withdrawal of cytotoxic chemotherapy and immunosuppressive therapy in hepatitis B carriers. Q J Med (1989) 1.57
Immunoglobulin A antibody to a 200-kilodalton cytosolic acetaldehyde adduct in alcoholic hepatitis. Gastroenterology (1992) 1.53
Cytomegalovirus infection persists in the liver graft in the vanishing bile duct syndrome. Hepatology (1992) 1.52
Accuracy of hepatocellular carcinoma detection on multidetector CT in a transplant liver population with explant liver correlation. Clin Radiol (2011) 1.50
Protoporphyria. Semin Liver Dis (1998) 1.49
Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications. J Hepatol (1992) 1.46
The Janes Surgical Society. Can J Surg (1999) 1.46
The role for liver biopsy in haemophiliacs infected with the hepatitis C virus. Br J Haematol (1997) 1.45
DNA targets for certain bZIP proteins distinguished by an intrinsic bend. Science (1994) 1.42
Risk of inappropriate exclusion of organ donors by introduction of hepatitis B core antibody testing. Transplantation (1997) 1.39
European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology (1999) 1.38
Human hepatic glyceraldehyde-3-phosphate dehydrogenase binds to the poly(U) tract of the 3' non-coding region of hepatitis C virus genomic RNA. J Gen Virol (1999) 1.38
Magnetic resonance imaging of the knee: diagnostic performance studies. Clin Radiol (1996) 1.36
Causes of morbilliform rash in a highly immunised English population. Arch Dis Child (2002) 1.35
Contrasting relations between suppressor-cell function and suppressor-cell number in chronic liver disease. Lancet (1983) 1.35
Effect of corticosteroids on suppressor-cell activity in "autoimmune" and viral chronic active hepatitis. N Engl J Med (1982) 1.26
Outcome of orthotopic liver transplantation in the aetiological and clinical variants of acute liver failure. Q J Med (1988) 1.24
Pandemic (H1N1) 2009 influenza in the UK: clinical and epidemiological findings from the first few hundred (FF100) cases. Epidemiol Infect (2010) 1.23
T lymphocyte sensitization to HBcAg and T cell-mediated unresponsiveness to HBsAg in hepatitis B virus-related chronic liver disease. Hepatology (1985) 1.20
Hypertriglyceridaemia in subjects with normal and abnormal glucose tolerance: relative contributions of insulin secretion, insulin resistance and suppression of plasma non-esterified fatty acids. Diabetologia (1994) 1.18
Detection of genomic and intermediate replicative strands of hepatitis C virus in liver tissue by in situ hybridization. J Clin Invest (1993) 1.17
Epidemiological study of latent and recent infection by Toxoplasma gondii in pregnant women from a regional population in the U.K. J Infect (1998) 1.16
Relationship between expression of hepatitis B virus antigens in isolated hepatocytes and autologous lymphocyte cytotoxicity in patients with chronic hepatitis B virus infection. Hepatology (1984) 1.16
Toxoplasmosis in cardiac transplantation. Br Med J (Clin Res Ed) (1986) 1.15
Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection. Gastroenterology (1988) 1.15
High prevalence of hepatitis C infection in Afro-Caribbean patients with type 2 diabetes and abnormal liver function tests. Diabet Med (1995) 1.12
High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis. Gastroenterology (1992) 1.12
Detection of hepatitis B virus antigens in liver tissue. A relation to viral replication and histology in chronic hepatitis B infection. Gastroenterology (1990) 1.12
Prevalence of alcohol histories in medical and nursing notes of patients admitted with self poisoning. BMJ (1995) 1.12
Detection of hepatitis B virus DNA in spermatozoa, urine, saliva and leucocytes, of chronic HBsAg carriers. A lack of relationship with serum markers of replication. J Hepatol (1987) 1.08
Heart-lung transplantation for end-stage respiratory disease in patients with cystic fibrosis at Papworth Hospital. J Heart Lung Transplant (1994) 1.06
Quality-of-life improvement compared after hip and knee replacement. J Bone Joint Surg Br (1996) 1.05
The importance of cytomegalovirus in heart-lung transplant recipients. Chest (1989) 1.04
Tumour necrosis factor to treat chronic hepatitis B virus infection. Lancet (1990) 1.04
Increased production of tumour necrosis factor alpha in chronic hepatitis B virus infection. J Hepatol (1991) 1.02
Spontaneous production of tumour necrosis factor alpha and interleukin-1 beta during interferon-alpha treatment of chronic HBV infection. Lancet (1990) 1.02
Pyrophosphate arthropathy: a clinical and radiological study of 105 cases. Ann Rheum Dis (1982) 1.01
Hepatitis B virus surface mutations associated with infection after liver transplantation. J Hepatol (1996) 1.00
The safety and value of extradural intracranial pressure monitors in fulminant hepatic failure. J Hepatol (1993) 1.00
Treatment of graft-versus-host disease after liver transplantation with basiliximab followed by bowel resection. Am J Transplant (2003) 1.00
Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection. J Viral Hepat (1998) 1.00
Diagnosis of toxoplasma infection in cardiac transplant recipients using the polymerase chain reaction. J Clin Pathol (1992) 0.99
Antibody-directed complement-mediated cytotoxicity to hepatocytes from patients with chronic hepatitis B. Clin Exp Immunol (1995) 0.99
Incidence, character and clinical relevance of mixed cryoglobulinaemia in patients with chronic hepatitis C virus infection. Clin Exp Immunol (1996) 0.99
Randomized trial to evaluate the clinical benefits of serum alpha-glutathione S-transferase concentration monitoring after liver transplantation. Transplantation (1997) 0.99
T and B cell function in alcoholic liver disease. J Hepatol (1986) 0.98
Adolescent milk, dairy product and fruit consumption and testicular cancer. Br J Cancer (1996) 0.98
Is revision as good as primary hip replacement? A comparison of quality of life. J Bone Joint Surg Br (1999) 0.98
Factors which influence the facial nerve outcome in vestibular schwannoma surgery. Clin Otolaryngol Allied Sci (1996) 0.96
Detection of HBV-DNA using a digoxigenin-labelled probe. A rapid technique without loss of sensitivity. J Hepatol (1991) 0.96
Incidence of vertebral fractures in the first three months after orthotopic liver transplantation. Eur J Gastroenterol Hepatol (2000) 0.93
Risk factors, clinical features and genotype distribution of diagnosed hepatitis C virus infections: a pilot for a sentinel laboratory-based surveillance. Commun Dis Public Health (2003) 0.93
Donor arterial variations in liver transplantation: management and outcome of 527 consecutive grafts. Br J Surg (1996) 0.92
Bronchoalveolar lavage and transbronchial lung biopsy during acute rejection and infection in heart-lung transplant patients. Studies of cell counts, lymphocyte phenotypes, and expression of HLA-DR and interleukin-2 receptor. Am Rev Respir Dis (1993) 0.91
Dose-dependent increase in plasma interleukin-6 after recombinant tumour necrosis factor infusion in humans. Clin Exp Immunol (1990) 0.91
Trends in deaths from malignant neoplasia of liver are poor indicator of hepatitis C infection. BMJ (1999) 0.91
The effect of temperature on digestive and assimilation efficiency, gut passage time and appetite in an ambush foraging lizard, Cordylus melanotus melanotus. J Comp Physiol B (2003) 0.91
Gilbert's syndrome: an overview for clinical biochemists. Ann Clin Biochem (2006) 0.90
TNF alpha in stool as marker of intestinal inflammation. Lancet (1992) 0.90
Blood-pressure-lowering treatment. Lancet (2001) 0.90
Validation of the continuous glucose monitoring sensor in preterm infants. Arch Dis Child Fetal Neonatal Ed (2012) 0.90
High prevalence of osteoporosis in patients with chronic liver disease prior to liver transplantation. Calcif Tissue Int (2001) 0.89
Functional characterization of peripheral blood lymphocytes in chronic HBsAg carriers. Clin Exp Immunol (1986) 0.89